WIN CONSORTIUM IN THE PRESS
2013-02-22
Global Leaders in Oncology Voice Support for WIN Consortium's 2013 Symposium in Personalized Cancer Medicine
read more »
MEMBER LOGIN
NEWSLETTER
Subscribe to our newsletter:
WELCOME
"The WIN Consortium offers an opportunity to make an impact on personalized cancer therapy across the globe by increasing the number of patients having access to innovative clinical trials and treatment with the latest innovative drugs."
- Dr. John Mendelsohn, Director, Khalifa Institute for Personalized Cancer Therapy and Past-President, The University of Texas MD Anderson Cancer Center; Chairman, WIN Consortium
WIN 2013 Symposium
Global oncology leaders Dr. John Mendelsohn (MD Anderson), Dr. Richard Buller (Pfizer), and Richard L. Schilsky (ASCO) discuss the goal of the WIN 2013 Symposium, to be held July 10-12 in Paris, France.
Interview with Dr. Alexander Eggermont
Dr. Alexander Eggermont, WIN Consortium Vice-Chair and Director General, Institut Gustave Roussy (France) discusses the importance and impact of the WIN Symposium.
